Researchers have established that the withdrawal of β-blocker therapy following a myocardial infarction (MI) results in ...

Zanubrutinib shows durable efficacy in CLL/SLL with 17p deletions, according to 5-year SEQUOIA trial data.

The programs, in which EMS workers make home visits to patients, have helped curb expensive hospital visits, say providers.

A new medication called lorundrostat has shown strong potential as a treatment for people with uncontrolled or resistant high ...

A new study finds that both the Mediterranean and keto diets can help lower a person’s blood pressure, support weight loss, ...

Among patients with pulmonary arterial hypertension treated with selexipag, the 10-year survival rate was 60%, according to ...

Medically reviewed by Jeffrey S. Lander, MD Hypertension (high blood pressure) occurs when the blood pressure against your ...

Intensive blood pressure management may lower the risk of developing dementia or cognitive impairment without dementia.

The findings hint at why the ABYSS trial failed to show it was safe to stop beta-blockers after an MI in stable patients.

Patients with worse glaucoma severity were more likely to experience steroid-induced ocular hypertension, according to a ...

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease.